Alcohol Use Disorder Increases the Risk of Irritable Bowel Disease: A Nationwide Retrospective Cohort Study
- PMID: 26705226
- PMCID: PMC4697992
- DOI: 10.1097/MD.0000000000002334
Alcohol Use Disorder Increases the Risk of Irritable Bowel Disease: A Nationwide Retrospective Cohort Study
Abstract
Alcohol use disorder (AUD) is considered a possible risk factor for irritable bowel syndrome (IBS); however, previous studies investigating the association between AUD and IBS have yielded inconsistent results. The study investigated whether AUD increases the risk of IBS by using a population-based database in Taiwan.This retrospective matched-cohort study included the health insurance claims data of 56,355 AUD inpatients and 225,420 randomly selected controls by frequency-matched for sex, age, and index year. Cox proportional hazards regression analysis was performed to measure the risk of IBS among AUD patients compared with non-AUD patients.During the follow-up period, the incidence rate ratio (IRR) of IBS had 12.3-fold (95% CI: 11.9-12.7) in the AUD patients than non-AUD patients and the adjusted hazard ratio (aHR) for IBS in the AUD patients was 5.51 (95% CI: 4.36-6.96). For several comorbidities, the risk of IBS was significantly higher in the AUD patients than in non-AUD patients, with aHRs of 2.14 (95% confidence interval [CI]: 1.19-3.84), 2.05 (95% CI: 1.06-3.96), and 2.91 (95% CI: 1.26-6.72) for sleep disorders, acute pancreatitis, and hepatitis B, respectively. When we stratified the severity of AUD according to the length of hospital stay, the aHRs exhibited a significant correlation (P < 0.001) with severity, yielding aHRs of 3.24 (95% CI: 2.49-4.22), 11.9 (95% CI: 8.96-15.9), and 26.1 (95% CI: 19.4-35.2) for mild, moderate, and severe AUD, respectively.The risk of IBS was higher among AUD patients, and increased with the length of hospital stay.
Conflict of interest statement
All authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Alcohol use disorder increases the risk of necrotizing fasciitis: A nationwide retrospective cohort study.Medicine (Baltimore). 2017 Aug;96(32):e7509. doi: 10.1097/MD.0000000000007509. Medicine (Baltimore). 2017. PMID: 28796035 Free PMC article.
-
Bidirectional Association between Asthma and Irritable Bowel Syndrome: Two Population-Based Retrospective Cohort Studies.PLoS One. 2016 Apr 19;11(4):e0153911. doi: 10.1371/journal.pone.0153911. eCollection 2016. PLoS One. 2016. PMID: 27093172 Free PMC article.
-
Irritable Bowel Syndrome Increases the Risk of Epilepsy: A Population-Based Study.Medicine (Baltimore). 2015 Sep;94(36):e1497. doi: 10.1097/MD.0000000000001497. Medicine (Baltimore). 2015. PMID: 26356716 Free PMC article.
-
Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.PLoS One. 2015 Jul 29;10(7):e0133283. doi: 10.1371/journal.pone.0133283. eCollection 2015. PLoS One. 2015. PMID: 26222511 Free PMC article.
-
Association between migraine and irritable bowel syndrome: a population-based retrospective cohort study.Eur J Neurol. 2014 Sep;21(9):1198-204. doi: 10.1111/ene.12468. Epub 2014 May 17. Eur J Neurol. 2014. PMID: 24838228
Cited by
-
Prevalence and risk factor for chronic diarrhea in participants of a Japanese medical checkup.JGH Open. 2021 Dec 29;6(1):69-75. doi: 10.1002/jgh3.12704. eCollection 2022 Jan. JGH Open. 2021. PMID: 35071791 Free PMC article.
-
Alcohol as friend or foe in autoimmune diseases: a role for gut microbiome?Gut Microbes. 2021 Jan-Dec;13(1):1916278. doi: 10.1080/19490976.2021.1916278. Gut Microbes. 2021. PMID: 34224314 Free PMC article. Review.
-
Cross-Cohort Gut Microbiome Signatures of Irritable Bowel Syndrome Presentation and Treatment.Adv Sci (Weinh). 2024 Nov;11(41):e2308313. doi: 10.1002/advs.202308313. Epub 2024 Sep 7. Adv Sci (Weinh). 2024. PMID: 39243395 Free PMC article.
-
Randomized controlled study of efficacy and safety of drotaverine hydrochloride in patients with irritable bowel syndrome.Medicine (Baltimore). 2017 Dec;96(51):e9235. doi: 10.1097/MD.0000000000009235. Medicine (Baltimore). 2017. PMID: 29390477 Free PMC article.
References
-
- Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA 2015; 313:949–958. - PubMed
-
- Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther 2003; 18:671–682. - PubMed
-
- Moshiree B, Price DD, Robinson ME, et al. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia. Clin J Pain 2007; 23:323–330. - PubMed
-
- Wood JD. Neuropathophysiology of irritable bowel syndrome. J Clin Gastroenterol 2002; 35:S11–22. - PubMed
-
- Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136:1979–1988. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources